V

Versatope Therapeutics

14 employees

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
vaccine
drug delivery
oncology

Date founded

2017

Funding rounds raised

Total raised

$18M

from 2 investors over 2 rounds

V

Versatope Therapeutics raised $300K on September 9, 2020

Investors: Massachusetts Life Sciences Center

V

Versatope Therapeutics raised $18M on September 26, 2018

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ